Keyphrases
A1 Receptor
11%
Amyloid Precursor Protein
22%
Antidiabetic
11%
Antidiabetic Drugs
11%
Brain Diseases
11%
Clinical Score
55%
Directing Attention
11%
Disease Onset
11%
Disease Severity
22%
Drug Treatment
11%
Experimental Autoimmune Encephalomyelitis
100%
Glial Fibrillary Acidic Protein
22%
Glucagon-like
100%
Healthy Controls
11%
Humane Endpoints
22%
Imaging Biomarkers
11%
Lewis Rats
100%
Liraglutide
100%
Manganese Superoxide Dismutase (MnSOD)
22%
Metabolic Disturbances
11%
Metformin
11%
Mitochondria-targeted Antioxidants
11%
Model Experimental
11%
Multiple Sclerosis
33%
Neuroprotective
11%
Oxidative Stress
11%
Pioglitazone
11%
Potential Therapy
11%
Protective Capacity
11%
Protein Level
22%
Receptor Agonist
11%
Treatment Delay
11%
Twice Daily
11%
Weight Reducing
11%
Immunology and Microbiology
Agonist
25%
Body Weight Loss
25%
Drug Therapy
25%
Experimental Allergic Encephalitis
100%
Experimental Model
50%
Glucagon-Like Peptide-1
100%
Lewis Rat
100%
Multiple Sclerosis
75%
Oxidative Stress
25%
Precursor
50%
Superoxide Dismutase
50%
Pharmacology, Toxicology and Pharmaceutical Science
Amyloid Precursor Protein
22%
Anti-Inflammatory Drug
11%
Antidiabetic Agent
22%
Antioxidant
11%
Brain Disease
11%
Disease Severity
22%
Diseases
11%
Glial Fibrillary Acidic Protein
22%
Glucagon Like Peptide 1 Receptor Agonist
11%
Glucagon-Like Peptide-1
100%
Lewis Rat
100%
Liraglutide
100%
Manganese Superoxide Dismutase
22%
Metabolic Disorder
11%
Metformin
11%
Multiple Sclerosis
33%
Neuroprotective Agent
11%
Pharmacotherapy
11%
Pioglitazone
11%
Sphingolipid Activator Protein 2
11%
Table Salt
11%